Home | Welcome to Contract Pharma   
Last Updated Wednesday, May 27 2015


Trials & Filings in Brief: Sept. 25, 2013

Acorda, Amarin, Bayer, Cardiome, Cornerstone, KemPharm, Merck Serono and Mylan

By Gil Roth

Published September 25, 2013
Related Searches: contractpharma contractpharma.com Phase II Phase III
Phase II
Cornerstone begins trial for myelodysplastic syndrome . . . read more

Acorda enrolls for spinal injury trial . . . read more

Phase III
Merck Serono to conduct cancer immunotherapy trial . . . read more

Mylan sued over first-to-file challenge of Savella . . . read more

Amarin enrolls 6,000+ in REDUCE-IT CV trial . . . read more

Cardiome gains Brinavess approval in Turkey . . . read more

KemPharm's abuse-resistant opioid shows equivalence to RLD . . . read more

Bayer receives orphan status for riociguat . . . read more

blog comments powered by Disqus

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On